Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis.

Sommars MA, Ramachandran K, Senagolage MD, Futtner CR, Germain DM, Allred AL, Omura Y, Bederman IR, Barish GD.

Elife. 2019 Apr 15;8. pii: e43922. doi: 10.7554/eLife.43922.

2.

Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity.

Senagolage MD, Sommars MA, Ramachandran K, Futtner CR, Omura Y, Allred AL, Wang J, Yang C, Procissi D, Evans RM, Han X, Bederman IR, Barish GD.

Cell Rep. 2018 Dec 18;25(12):3283-3298.e6. doi: 10.1016/j.celrep.2018.11.074.

3.

Requirement for NF-κB in maintenance of molecular and behavioral circadian rhythms in mice.

Hong HK, Maury E, Ramsey KM, Perelis M, Marcheva B, Omura C, Kobayashi Y, Guttridge DC, Barish GD, Bass J.

Genes Dev. 2018 Nov 1;32(21-22):1367-1379. doi: 10.1101/gad.319228.118. Epub 2018 Oct 26.

4.

Genomic integration of ERRγ-HNF1β regulates renal bioenergetics and prevents chronic kidney disease.

Zhao J, Lupino K, Wilkins BJ, Qiu C, Liu J, Omura Y, Allred AL, McDonald C, Susztak K, Barish GD, Pei L.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):E4910-E4919. doi: 10.1073/pnas.1804965115. Epub 2018 May 7.

5.

A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating Inflammation.

Tong AJ, Liu X, Thomas BJ, Lissner MM, Baker MR, Senagolage MD, Allred AL, Barish GD, Smale ST.

Cell. 2016 Mar 24;165(1):165-179. doi: 10.1016/j.cell.2016.01.020. Epub 2016 Feb 25.

6.

Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.

Perelis M, Marcheva B, Ramsey KM, Schipma MJ, Hutchison AL, Taguchi A, Peek CB, Hong H, Huang W, Omura C, Allred AL, Bradfield CA, Dinner AR, Barish GD, Bass J.

Science. 2015 Nov 6;350(6261):aac4250. doi: 10.1126/science.aac4250.

7.

Dependence of hippocampal function on ERRγ-regulated mitochondrial metabolism.

Pei L, Mu Y, Leblanc M, Alaynick W, Barish GD, Pankratz M, Tseng TW, Kaufman S, Liddle C, Yu RT, Downes M, Pfaff SL, Auwerx J, Gage FH, Evans RM.

Cell Metab. 2015 Apr 7;21(4):628-36. doi: 10.1016/j.cmet.2015.03.004.

8.

Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.

van Stijn CM, Kim J, Lusis AJ, Barish GD, Tangirala RK.

FASEB J. 2015 Feb;29(2):636-49. doi: 10.1096/fj.14-253831. Epub 2014 Nov 12.

9.

A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.

Kim JY, Banerjee T, Vinckevicius A, Luo Q, Parker JB, Baker MR, Radhakrishnan I, Wei JJ, Barish GD, Chakravarti D.

Mol Cell. 2014 May 22;54(4):613-25. doi: 10.1016/j.molcel.2014.03.043. Epub 2014 May 1. Erratum in: Mol Cell. 2015 May 7;58(3):557.

10.

Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis.

van Stijn CM, Kim J, Barish GD, Tietge UJ, Tangirala RK.

PLoS One. 2014 Jan 22;9(1):e86404. doi: 10.1371/journal.pone.0086404. eCollection 2014.

11.

Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.

Hong SH, Dvorak-Ewell M, Stevens HY, Barish GD, Castro GL, Nofsinger R, Frangos JA, Shoback D, Evans RM.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18820-5. doi: 10.1073/pnas.1318974110. Epub 2013 Nov 4.

12.

Chromatin immunoprecipitation.

Barish GD, Tangirala RK.

Methods Mol Biol. 2013;1027:327-42. doi: 10.1007/978-1-60327-369-5_15.

PMID:
23912994
13.

A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.

Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM.

Cell. 2013 Apr 25;153(3):601-13. doi: 10.1016/j.cell.2013.03.028.

14.

Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes.

Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, Liddle C, Schwalie P, Hübner N, Evans RM.

Mol Cell. 2013 Jan 10;49(1):158-71. doi: 10.1016/j.molcel.2012.10.013. Epub 2012 Nov 15.

15.

The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice.

Richards MR, Black AS, Bonnet DJ, Barish GD, Woo CW, Tabas I, Curtiss LK, Tobias PS.

Innate Immun. 2013 Feb;19(1):20-9. doi: 10.1177/1753425912447130. Epub 2012 May 25.

16.

The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis.

Barish GD, Yu RT, Karunasiri MS, Becerra D, Kim J, Tseng TW, Tai LJ, Leblanc M, Diehl C, Cerchietti L, Miller YI, Witztum JL, Melnick AM, Dent AL, Tangirala RK, Evans RM.

Cell Metab. 2012 Apr 4;15(4):554-62. doi: 10.1016/j.cmet.2012.02.012. Epub 2012 Mar 29.

17.

Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β.

Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, Liddle C, Auwerx J, Downes M, Panda S, Evans RM.

Nature. 2012 Mar 29;485(7396):123-7. doi: 10.1038/nature11048.

18.

Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.

Lamia KA, Papp SJ, Yu RT, Barish GD, Uhlenhaut NH, Jonker JW, Downes M, Evans RM.

Nature. 2011 Dec 14;480(7378):552-6. doi: 10.1038/nature10700.

19.

NCoR1 is a conserved physiological modulator of muscle mass and oxidative function.

Yamamoto H, Williams EG, Mouchiroud L, Cantó C, Fan W, Downes M, Héligon C, Barish GD, Desvergne B, Evans RM, Schoonjans K, Auwerx J.

Cell. 2011 Nov 11;147(4):827-39. doi: 10.1016/j.cell.2011.10.017.

20.

Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.

Diehl CJ, Barish GD, Downes M, Chou MY, Heinz S, Glass CK, Evans RM, Witztum JL.

Mol Endocrinol. 2011 Mar;25(3):529-45. doi: 10.1210/me.2010-0384. Epub 2011 Jan 27.

21.

Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response.

Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, Benner C, Dent AL, Tangirala RK, Evans RM.

Genes Dev. 2010 Dec 15;24(24):2760-5. doi: 10.1101/gad.1998010. Epub 2010 Nov 24.

22.

PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization.

Sugii S, Olson P, Sears DD, Saberi M, Atkins AR, Barish GD, Hong SH, Castro GL, Yin YQ, Nelson MC, Hsiao G, Greaves DR, Downes M, Yu RT, Olefsky JM, Evans RM.

Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22504-9. doi: 10.1073/pnas.0912487106. Epub 2009 Dec 16.

23.

SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis.

Nofsinger RR, Li P, Hong SH, Jonker JW, Barish GD, Ying H, Cheng SY, Leblanc M, Xu W, Pei L, Kang YJ, Nelson M, Downes M, Yu RT, Olefsky JM, Lee CH, Evans RM.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):20021-6. doi: 10.1073/pnas.0811012105. Epub 2008 Dec 9.

24.

PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis.

Barish GD, Atkins AR, Downes M, Olson P, Chong LW, Nelson M, Zou Y, Hwang H, Kang H, Curtiss L, Evans RM, Lee CH.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4271-6. doi: 10.1073/pnas.0711875105. Epub 2008 Mar 12.

25.

PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.

Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, Atkins AR, Downes M, Barish GD, Evans RM, Hsueh WA, Tangirala RK.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4277-82. doi: 10.1073/pnas.0708647105. Epub 2008 Mar 12.

26.

Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation.

Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, Chang S, Jiang Y, Evans RM, Elias PM, Feingold KR.

J Invest Dermatol. 2008 Feb;128(2):370-7. Epub 2007 Aug 23.

27.

Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense.

Sonoda J, Laganière J, Mehl IR, Barish GD, Chong LW, Li X, Scheffler IE, Mock DC, Bataille AR, Robert F, Lee CH, Giguère V, Evans RM.

Genes Dev. 2007 Aug 1;21(15):1909-20.

28.

PPAR delta: a dagger in the heart of the metabolic syndrome.

Barish GD, Narkar VA, Evans RM.

J Clin Invest. 2006 Mar;116(3):590-7. Review.

29.
30.

A Nuclear Receptor Atlas: macrophage activation.

Barish GD, Downes M, Alaynick WA, Yu RT, Ocampo CB, Bookout AL, Mangelsdorf DJ, Evans RM.

Mol Endocrinol. 2005 Oct;19(10):2466-77. Epub 2005 Jul 28.

PMID:
16051664
31.

Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites.

Sonoda J, Chong LW, Downes M, Barish GD, Coulter S, Liddle C, Lee CH, Evans RM.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2198-203. Epub 2005 Jan 25.

32.

A nuclear strike against Listeria--the evolving life of LXR.

Barish GD, Evans RM.

Cell. 2004 Oct 15;119(2):149-51.

33.

PPARs and LXRs: atherosclerosis goes nuclear.

Barish GD, Evans RM.

Trends Endocrinol Metab. 2004 May-Jun;15(4):158-65. Review.

PMID:
15109614
34.

PPARs and the complex journey to obesity.

Evans RM, Barish GD, Wang YX.

Nat Med. 2004 Apr;10(4):355-61. Review.

PMID:
15057233
35.

A comparative evaluation of beta-catenin and plakoglobin signaling activity.

Williams BO, Barish GD, Klymkowsky MW, Varmus HE.

Oncogene. 2000 Nov 23;19(50):5720-8.

36.

Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin.

Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE.

Mol Cell. 1999 Oct;4(4):487-98.

37.

Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling.

Klymkowsky MW, Williams BO, Barish GD, Varmus HE, Vourgourakis YE.

Mol Biol Cell. 1999 Oct;10(10):3151-69.

Supplemental Content

Loading ...
Support Center